We are proud to announce a new publication in Autophagy Reports from ONJCRI researchers, shedding light on the critical role of BECLIN1 in maintaining gut health. The study, led by PhD student Juliani Juliani and co-senior authored by A/Prof Doug Fairlie and A/Prof Erinna Lee, reveals that BECLIN1 is essential for preserving the structural integrity of the gut and preventing inflammation.
A Gatekeeper for Gut Integrity
Using a preclinical model, the research team demonstrated that the deletion of BECLIN1 from cells lining the gut resulted in severe and rapidly fatal inflammation. The loss of this protein led to the breakdown of the gut barrier, triggering a cascade of cellular stress and tissue damage.
Although BECLIN1 is widely recognised for its role in autophagy – a cellular recycling and clean-up process – this study highlights its additional and equally vital functions in:
- Endocytic trafficking
- Cell structure regulation
- Lysosomal function
These cellular mechanisms are critical to maintaining gut epithelial integrity and overall gut health.
- BECLIN1-deficient gut cells experienced severe stress and cell death
- E-cadherin, a key protein responsible for cell-to-cell adhesion, was mislocalised, compromising cellular junctions
- Loss of ATG7, another essential autophagy gene, did not replicate the same effects – suggesting that BECLIN1 has distinct roles beyond autophagy
These findings extend ONJCRI’s previous work positioning BECLIN1 as a master regulator of gut homeostasis and help unravel the cellular mechanisms contributing to inflammatory bowel disease (IBD). IBD is not only a chronic condition that significantly impacts quality of life, but it also increases the risk of developing colorectal cancer.
Key Findings
- BECLIN1-deficient gut cells experienced severe stress and cell death
- E-cadherin, a key protein responsible for cell-to-cell adhesion, was mislocalised, compromising cellular junctions
- Loss of ATG7, another essential autophagy gene, did not replicate the same effects – suggesting that BECLIN1 has distinct roles beyond autophagy
These findings extend ONJCRI’s previous work positioning BECLIN1 as a master regulator of gut homeostasis and help unravel the cellular mechanisms contributing to inflammatory bowel disease (IBD). IBD is not only a chronic condition that significantly impacts quality of life, but it also increases the risk of developing colorectal cancer.
A Step Toward New Therapies
Current IBD treatments primarily focus on managing symptoms. However, research like this opens the door to targeting the underlying molecular drivers of gut inflammation – offering a path to more effective and lasting therapeutic solutions.
Juliani Juliani – PhD Student
A Collaborative Effort
This research was made possible through the combined efforts of ONJCRI’s Cell Death and Survival and Oncogenic Transcription laboratories, the ONJCRI Imaging Platform led by Prof Sarah Ellis, and collaborators from the University of Melbourne and the University of Queensland.
???? Read the full publication in Autophagy Reports:
https://doi.org/10.1080/27694127.2025.2484494